University of Aberdeen United Kingdom.
University of Edinburgh United Kingdom.
J Am Heart Assoc. 2022 Jul 19;11(14):e025989. doi: 10.1161/JAHA.122.025989. Epub 2022 Jul 13.
Background We investigate if renin-angiotensin and endothelin-1 response pathways follow the same pattern of recovery as left ventricular ejection fraction in patients with takotsubo cardiomyopathy. Methods and Results Ninety patients with takotsubo cardiomyopathy (n=30 in each of "acute," "convalescent" [3-5 months] and "recovered" [>1 year] groups) who were on minimal or no medication and were free of any significant cardiac/metabolic comorbidities, and 30 controls were studied. Serum concentrations of renin, angiotensin-converting enzyme, angiotensin II, big endothelin-1, endothelin-1 were measured using commercially available ELISA, and B-type natriuretic peptide was measured using an immunoassay. Mean left ventricular ejection fraction was <40% during the acute phase in all groups, but recovered to 63% in convalescent and 64% in the recovered groups, respectively. Serum renin concentrations remain persistently elevated after a episode of takotsubo cardiomyopathy (=0.03 versus controls). Angiotensin converting enzyme levels are significantly depressed during the acute phase compared with convalescent (=0.004), recovered takotsubo cardiomyopathy (=0.02) or controls (=0.03). Angiotensin II is increased in patients with takotsubo cardiomyopathy (<0.001 versus controls) remaining persistently elevated in the chronically recovered group alone (=0.03 versus controls). Big endothelin-1 levels are unchanged, but endothelin-1 is significantly lower after takotsubo cardiomyopathy compared with controls (=0.03). Conclusions Despite "normalization" of the left ventricular ejection fraction, there is long-term maladaptive activation of renin-angiotensin system in patients with takotsubo cardiomyopathy. Registration URL: https://www.clinicaltrials.gov; Unique identifiers: NCT02897739, NCT02989454.
我们研究了在 Takotsubo 心肌病患者中,肾素-血管紧张素和内皮素-1 反应途径是否遵循与左心室射血分数相同的恢复模式。
共 90 例 Takotsubo 心肌病患者(急性组 n=30,缓解期[3-5 个月] n=30,恢复期[>1 年] n=30)和 30 例对照者纳入研究。所有患者均处于最小或无药物治疗状态,且无任何严重的心脏/代谢合并症。采用商业 ELISA 法测定肾素、血管紧张素转换酶、血管紧张素Ⅱ、大内皮素-1、内皮素-1 浓度,采用免疫法测定 B 型利钠肽浓度。所有患者在急性阶段的平均左心室射血分数均<40%,但在缓解期分别恢复至 63%,在恢复期恢复至 64%。Takotsubo 心肌病发作后,血清肾素浓度持续升高(=0.03 与对照组)。与缓解期(=0.004)、恢复期 Takotsubo 心肌病(=0.02)或对照组(=0.03)相比,急性阶段血管紧张素转换酶水平显著降低。Takotsubo 心肌病患者的血管紧张素Ⅱ升高(<0.001 与对照组),仅在慢性恢复期持续升高(=0.03 与对照组)。大内皮素-1 水平无变化,但 Takotsubo 心肌病后内皮素-1 水平显著低于对照组(=0.03)。
尽管左心室射血分数“正常化”,但 Takotsubo 心肌病患者的肾素-血管紧张素系统长期存在适应性激活。
https://www.clinicaltrials.gov;独特标识符:NCT02897739,NCT02989454。